Back to News
Market Impact: 0.45

Designer Brands Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

DBIUBS
Corporate EarningsAnalyst EstimatesCorporate Guidance & OutlookCompany FundamentalsAnalyst InsightsConsumer Demand & Retail
Designer Brands Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Designer Brands Inc. (DBI) is scheduled to report its Q2 earnings on September 9, with analysts projecting a decline in performance to $0.22 per share on $737.85 million in revenue, down from $0.29 per share and $771.9 million year-over-year. This anticipated downturn follows a worse-than-expected Q1 and the company's withdrawal of its FY25 guidance due to macroeconomic uncertainty. Despite these headwinds, DBI shares recently gained 11.1% to close at $4.41, while analysts from UBS and Telsey Advisory Group maintain Neutral/Market Perform ratings, both with a $4 price target.

Analysis

Designer Brands Inc. (DBI) is approaching its second-quarter earnings release with significant headwinds, as analysts forecast a year-over-year decline in both revenue and profitability. Projections place quarterly EPS at $0.22, down from $0.29 in the prior-year period, and revenue at $737.85 million, compared to $771.9 million. This anticipated weakness follows a worse-than-expected first quarter and, critically, the company's withdrawal of its fiscal year 2025 guidance due to macroeconomic uncertainty, signaling a lack of management visibility. Despite these negative fundamental indicators and cautious analyst ratings—both UBS and Telsey Advisory Group maintain Neutral/Market Perform ratings with a $4.00 price target—DBI's shares recently surged 11.1% to close at $4.41. This creates a notable disconnect where the stock's current market price has surpassed analyst targets ahead of an earnings report widely expected to show deteriorating performance.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo